The Food and Drug Administration has recently approved two UNC-tested endovascular aortic repair devices.
Mark Farber, a doctor and director of UNC Aortic Disease Management, served as the national principal investigator for clinical trials of both devices.
Aortic Disease Management is part of the UNC Center for Heart and Vascular Care and conducts clinical trials for the advancement of aortic treatments.
The aorta is human body’s main artery and carries oxygen from the heart to the rest of the body.
Aortic disease can stretch, weaken or damage the aorta and is potentially fatal.
